Complicated Monkeypox Infection in a Patient With Multiple Sclerosis and Fingolimod Treatment

被引:2
|
作者
Mueller-Jensen, Leonie [1 ,3 ,4 ,5 ]
Kriedemann, Helene [2 ]
Anvari, Kerstin
Huehnchen, Petra [1 ,3 ,4 ,5 ]
Siffrin, Volker [1 ]
机构
[1] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
[5] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany
关键词
D O I
10.1212/WNL.0000000000206743
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 46-year old man with controlled relapsing-remitting multiple sclerosis (MS) and long-term fingolimod treatment developed multiple painful skin lesions (Figure, A). Outpatient skin swab revealed monkeypox virus infection. No fever was detected, but the disease course was complicated by prolonged cutaneous, oral and perianal manifestations, proctitis (Figure, B), gastrointestinal bleeding with the need for blood transfusions, lower leg phlegmon (Figure, C), lymphadenopathy, and hyperbilirubinemia. Furthermore, the patient presented acute urinary retention and hematuria.
引用
收藏
页码:670 / 671
页数:2
相关论文
共 50 条
  • [1] Hypothyroidism in multiple sclerosis patient during fingolimod treatment
    Flores, J.
    Rito, F.
    Torres, G.
    Jung, H.
    Trevino-Frenk, I.
    Corona, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 348 (1-2) : 272 - 273
  • [2] Fingolimod in treatment of multiple sclerosis
    Juszczak, Marek
    Gierach, Pawel
    Glabinski, Andrzej
    AKTUALNOSCI NEUROLOGICZNE, 2010, 10 (03): : 145 - 151
  • [3] Disseminated tuberculosis associated with fingolimod treatment in a patient with multiple sclerosis
    Ong, Stephanie
    Kibbler, Joseph
    Maxwell, Gemma
    Steer, John
    BMJ CASE REPORTS, 2024, 17 (01)
  • [4] Increased risk of disseminated cryptococcal infection in a patient with multiple sclerosis on fingolimod
    Kaur, Pushpinder
    Lewis, Alana
    Basit, Abdul
    St Cyr, Nikolas
    Muhammad, Zaman
    IDCASES, 2020, 22
  • [5] Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient
    Artemiadis, A. K.
    Nikolaou, G.
    Kolokythopoulos, D.
    Tegos, N.
    Terentiou, A.
    Triantafyllou, N.
    Papanastasiou, I.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 795 - 796
  • [6] COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
    Barzegar, Mahdi
    Mirmosayyeb, Omid
    Nehzat, Nasim
    Sarrafi, Reza
    Khorvash, Farzin
    Maghzi, Amir-Hadi
    Shaygannejad, Vahid
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (04):
  • [7] Is fingolimod an advancement in treatment of multiple sclerosis?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (03) : 383 - 386
  • [8] Fingolimod for the treatment of relapsing multiple sclerosis
    Jeffery, Douglas R.
    Markowitz, Clyde E.
    Reder, Anthony T.
    Weinstock-Guttman, Bianca
    Tobias, Kathy
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (02) : 165 - 183
  • [9] Fingolimod for the treatment of relapsing multiple sclerosis
    Singer, Barry A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (06) : 589 - 602
  • [10] Cryptococcal meningitis complicated by cerebellar ischemic strokes and obstructive hydrocephalus in a patient with multiple sclerosis on fingolimod
    Coleman, Kelsey
    Malone, Joseph
    Zeigler, Grant
    Fisher, Tiffany
    NEUROLOGY, 2020, 94 (15)